Concepedia

Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for Advanced Non–Small-Cell Lung Cancer

Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, James Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski

Journal of Thoracic Oncology · 2013 · 34 citations · 28 references

DOIFull text

Open access

Concepts

References

28

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

David Cella, David S. Tulsky, Geoffrey V. Gray et al. · Journal of Clinical Oncology · 1993 · 6K citations

, , +15

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

William J. Gradishar, Sergei Tjulandin, Neville Davidson et al. · Journal of Clinical Oncology · 2005 · 2.1K citations · Full text

, , +15

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.

Neil Desai, Vuong Trieu, Zhiwen Yao et al. · Clinical Cancer Research · 2006 · 1.2K citations

, , +14

Weekly <i>nab</i>-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Mark A. Socinski, Igor Bondarenko, Nina Karaseva et al. · Journal of Clinical Oncology · 2012 · 754 citations · Full text

, , +14